MicroPort Scientific (STU:MSK) Debt-to-Equity : 2.24 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is MicroPort Scientific Debt-to-Equity?

MicroPort Scientific's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €732.7 Mil. MicroPort Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €825.1 Mil. MicroPort Scientific's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €694.9 Mil. MicroPort Scientific's debt to equity for the quarter that ended in Dec. 2023 was 2.24.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for MicroPort Scientific's Debt-to-Equity or its related term are showing as below:

STU:MSK' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.26 Med: 0.89 Max: 2.24
Current: 2.24

During the past 13 years, the highest Debt-to-Equity Ratio of MicroPort Scientific was 2.24. The lowest was 0.26. And the median was 0.89.

STU:MSK's Debt-to-Equity is ranked worse than
96.04% of 707 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs STU:MSK: 2.24

MicroPort Scientific Debt-to-Equity Historical Data

The historical data trend for MicroPort Scientific's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort Scientific Debt-to-Equity Chart

MicroPort Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.88

0.26

0.83

1.29

2.24

MicroPort Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.83	1.05	1.29	1.64	2.24

Competitive Comparison of MicroPort Scientific's Debt-to-Equity

For the Medical Devices subindustry, MicroPort Scientific's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort Scientific's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort Scientific's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where MicroPort Scientific's Debt-to-Equity falls into.

MicroPort Scientific Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

MicroPort Scientific's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(732.671	+	825.08)	/	694.92
	=	2.24

MicroPort Scientific's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(732.671	+	825.08)	/	694.92
	=	2.24

MicroPort Scientific (STU:MSK) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

MicroPort Scientific Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of MicroPort Scientific's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort Scientific (STU:MSK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort Scientific Corp (STU:MSK) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

MCRPF:USA 00853:Hong Kong MSK:Germany

Address

1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Shanghai, CHN, 201203

Website

https://www.microport.com

MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacture, R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacture, R&D of orthopedics devices. CRM business: sales, manufacture, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacture, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacture, R&D of neurovascular devices. Heart valve business: sales, manufacture, R&D of heart valve devices. Surgical robot business: sales, manufacture, R&D of surgical robot devices. Surgical devices business: sales, manufacture, R&D of surgical devices. The key revenue is from The PRC.

MicroPort Scientific (STU:MSK) Headlines

No Headlines